ES2138970T3 - Medios de contraste. - Google Patents

Medios de contraste.

Info

Publication number
ES2138970T3
ES2138970T3 ES92907484T ES92907484T ES2138970T3 ES 2138970 T3 ES2138970 T3 ES 2138970T3 ES 92907484 T ES92907484 T ES 92907484T ES 92907484 T ES92907484 T ES 92907484T ES 2138970 T3 ES2138970 T3 ES 2138970T3
Authority
ES
Spain
Prior art keywords
pct
contrast
atoms
date
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92907484T
Other languages
English (en)
Inventor
Torsten Almen
Arne Berg
C Allen Chang
Michael Droege
Harald Dugstad
Jere D Fellman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amersham Health Salutar Inc
Original Assignee
Nycomed Salutar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919106579A external-priority patent/GB9106579D0/en
Application filed by Nycomed Salutar Inc filed Critical Nycomed Salutar Inc
Application granted granted Critical
Publication of ES2138970T3 publication Critical patent/ES2138970T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00Compounds containing elements of Groups 6 or 16 of the Periodic Table
    • C07F11/005Compounds containing elements of Groups 6 or 16 of the Periodic Table compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • C07F15/025Iron compounds without a metal-carbon linkage
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/903Specified use of nanostructure for conversion, containment, or destruction of hazardous material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927Diagnostic contrast agent
    • Y10S977/928X-ray agent
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927Diagnostic contrast agent
    • Y10S977/929Ultrasound contrast agent

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Liquid Crystal (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Materials For Medical Uses (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Lubricants (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Apparatus For Radiation Diagnosis (AREA)

Abstract

SE PRESENTA UN MEDIO DE CONTRASTE DE FORMACION DE IMAGENES QUE COMPRENDE UN COMPLEJO MULTINUCLEAR FISIOLOGICAMENTE TOLERABLE (COMO SE DEFINE EN LAS ESPECIFICACION 1). EL COMPLEJO MULTINUCLEAR CONTIENE AL MENOS DOS, PERO PREFERENTEMENTE TRES O MAS ATOMOS AUMENTADORES DE CONTRASTE. PARA TECNICAS DE FORMACION DE IMAGENES POR ULTRASONIDOS O POR RAYOS X SE UTILIZAN ATOMO DE METALES PESADOS PARA INCREMENTAR EL CONTRASTE, EN TANTO QUE EN LA FORMACION DE IMAGENES POR RESONANCIA MAGNETICA LOS ATOMOS DE METAL PARAMAGNETICO AUMENTA EL CONTRASTE. EL MOLIBDENO Y EL TUNGSTENO SON LOS ATOMOS AUMENTADORES DE CONTRASTE PREFERIDOS. EL MEDIO PUEDE TAMBIEN SER USADO TERAPEUTICAMENTE.
ES92907484T 1991-03-27 1992-03-27 Medios de contraste. Expired - Lifetime ES2138970T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919106579A GB9106579D0 (en) 1991-03-27 1991-03-27 Contrast media
GB919120507A GB9120507D0 (en) 1991-03-27 1991-09-26 Contrast media

Publications (1)

Publication Number Publication Date
ES2138970T3 true ES2138970T3 (es) 2000-02-01

Family

ID=26298647

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92907484T Expired - Lifetime ES2138970T3 (es) 1991-03-27 1992-03-27 Medios de contraste.

Country Status (15)

Country Link
US (2) US5482699A (es)
EP (1) EP0577675B1 (es)
JP (1) JPH06506449A (es)
AT (1) ATE187340T1 (es)
AU (1) AU660013B2 (es)
CA (1) CA2106976A1 (es)
DE (1) DE69230400T2 (es)
ES (1) ES2138970T3 (es)
FI (1) FI934194A (es)
HU (1) HUT65240A (es)
IE (1) IE920996A1 (es)
NO (1) NO933421L (es)
NZ (1) NZ242156A (es)
PH (1) PH29904A (es)
SG (1) SG43930A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4188196A (en) * 1994-12-22 1996-07-10 Nissan Chemical Industries Ltd. Organobismuth derivatives and process for producing the same
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
DE19507820A1 (de) 1995-02-21 1996-08-22 Schering Ag Neuartig substituierte DTPA-Derivate, deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik, sowie Verfahren zur Herstellung der Komplexe und Mittel
US5801228A (en) * 1995-06-07 1998-09-01 Nycomed Imaging As Polymeric contrast agents for medical imaging
US20050227294A1 (en) * 1997-09-15 2005-10-13 Molecular Devices Corporation Molecular modification assays involving lipids
US7632651B2 (en) * 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US7745142B2 (en) * 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US6596259B1 (en) 1998-12-22 2003-07-22 University Of Puerto Rico Metal based cubane structure contained in an octanuclear complex stable over several oxidation states and a method of producing the same
US7807137B1 (en) 1998-12-22 2010-10-05 University Of Puerto Rico Iron-based contrast agent
US20030215391A1 (en) * 2001-07-19 2003-11-20 Carlos Rabito Fluorescent agents for real-time measurement of organ function
US20050106100A1 (en) * 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
CA2581639C (en) * 2004-09-30 2016-07-26 Molecular Devices Corporation Luminescent lanthanide complexes
US7888297B2 (en) * 2005-01-06 2011-02-15 Halliburton Energy Services, Inc. Compositions for reducing the viscosity of treatment fluids
US8703097B2 (en) * 2005-02-11 2014-04-22 University Health Network Compositions and method for multimodal imaging
EP1896086A1 (en) * 2005-06-30 2008-03-12 Bristol-Myers Squibb Pharma Company Hydrazide conjugates as imaging agents
US20120148501A1 (en) * 2010-12-08 2012-06-14 Fred Geisler Radiological image enhancement with tantalum clusters
JP6032729B2 (ja) * 2012-05-08 2016-11-30 国立研究開発法人理化学研究所 イメージングマーカーおよびその利用
RU2667894C2 (ru) * 2013-02-06 2018-09-25 Пом Патентфервальтгунгс Гбр Гетерополиоксометаллаты
CN114573609B (zh) * 2022-03-07 2024-02-06 桂林理工大学 一种基于不对称双核镝配合物的单分子磁体及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE263059C (es) *
DE130934C (es) *
DE361960C (de) * 1920-06-01 1922-10-20 Georg Spiess Rundstapelbogenanleger
US3860611A (en) * 1972-01-19 1975-01-14 Du Pont Macrocyclic polyether polyols and condensation polymers derived therefrom
US3763188A (en) * 1972-01-19 1973-10-02 Du Pont Spiro(1,1-polyethylenedi(oxymethyl))-3-oxetanes
US3952015A (en) * 1973-11-12 1976-04-20 Carl George Krespan Macrocyclic compounds having oxa and aza linkages in the ring and containing spirooxetane groups
US4079124A (en) * 1976-04-21 1978-03-14 Medi-Physics, Inc. Method of preparing X-ray contrast media containing ores of hafnium, tantalum and tungsten
US4176173A (en) * 1977-07-18 1979-11-27 Medi-Physics, Inc. Radiographic compositions
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3324235A1 (de) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen Neue komplexbildner, komplexe und komplexsalze
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
US4826673A (en) * 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
IL83966A (en) * 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
DE3869251D1 (de) * 1987-07-16 1992-04-23 Nycomed As Aminopolycarbonsaeure und ihre derivate.
FR2630547A1 (fr) * 1988-04-22 1989-10-27 Centre Nat Rech Scient Marquage froid de molecules de nature peptidique ou proteique
US5213788A (en) * 1988-09-29 1993-05-25 Ranney David F Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement
AU628403B2 (en) * 1988-09-29 1992-09-17 Access Pharmaceuticals, Inc. Methods and compositions for magnetic resonance imaging
US5260050A (en) * 1988-09-29 1993-11-09 Ranney David F Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes
GB9006977D0 (en) * 1990-03-28 1990-05-23 Nycomed As Compositions
GB9007967D0 (en) * 1990-04-09 1990-06-06 Nycomed As Compounds

Also Published As

Publication number Publication date
CA2106976A1 (en) 1992-09-28
NO933421D0 (no) 1993-09-24
AU660013B2 (en) 1995-06-08
DE69230400T2 (de) 2000-08-03
AU1433892A (en) 1992-11-02
NO933421L (no) 1993-11-24
JPH06506449A (ja) 1994-07-21
US5932190A (en) 1999-08-03
FI934194A0 (fi) 1993-09-24
IE920996A1 (en) 1992-10-07
US5482699A (en) 1996-01-09
FI934194A (fi) 1993-11-23
SG43930A1 (en) 1997-11-14
PH29904A (en) 1996-09-16
HUT65240A (en) 1994-05-02
DE69230400D1 (de) 2000-01-13
EP0577675A1 (en) 1994-01-12
EP0577675B1 (en) 1999-12-08
HU9302735D0 (en) 1993-12-28
NZ242156A (en) 1994-07-26
ATE187340T1 (de) 1999-12-15

Similar Documents

Publication Publication Date Title
ES2138970T3 (es) Medios de contraste.
FI854488A0 (fi) Kontrastmedel.
CA2427590A1 (en) Evaluating disease progression using magnetic resonance imaging
FR2550449B1 (fr) Agents de relaxation specifiques d'organes ou de pathologies, utilisables pour modifier les contrastes en imagerie medicale par resonance magnetique nucleaire
ITSV980052A0 (it) Lettino porta paziente o simili, e macchina, in particolare per il rilevamento d'immagini in risonanza magnetica nucleare in conbinazione
DK0858294T3 (da) Nål, der er kompatibel med magnetisk resonans
ES2118934T3 (es) Medios de contraste.
ES2089245T3 (es) Agentes quelantes.
NO940115D0 (no) Kontrastmidler for roentgen- og magnettomografisk avbildning
SE9402880D0 (sv) New peptide derivatives
ATE167665T1 (de) Hydroxamat- und hydrazidderivate von polyaminen und ihre medizinische verwendung als chelatierende wirkstoffe
YU66199A (sh) Primena intravenoznih kontrastnih sredstava za projekcionu mamografiju
CS9100438A2 (en) New derivative of beta-phenylisoserine, method of its preparation and its application
Nesland Electron Microscopy: Tenth European Congress of Pathology, Athens 1-7 September 1985
Chen An investigation of the parallel predictor-corrector class of methods for the solution of ode's.
EE200100291A (et) Magnetresonantstomograafia kontrastaine
NO962831D0 (no) Kontrastmidler for röntgen og magnettomografisk avbildning

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 577675

Country of ref document: ES